Eventide Healthcare & Life Sciences FundETNHX
Type
Mutual fund
Peer group
US equity: Healthcare
Net assets
$1.6B
Expense ratio
1.51%
1-year return
+60.3%
3 years, a year
+14.6%
5 years, a year
+1.4%
Holdings
92
What it aims to do.
The Eventide Healthcare & Life Sciences Fund (the ?Healthcare & Life Sciences Fund? or the ?Fund?) seeks to achieve long-term capital appreciation.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| GH Guardant Health Inc | 4.08% |
| MIRM Mirum Pharmaceuticals Inc. | 4.02% |
| INSM Insmed Inc | 3.78% |
| US Bank Mmda | 3.65% |
| BeLite Bio Inc | 3.30% |
| KYMR Kymera Therapeutics Inc | 3.28% |
| PCVX Vaxcyte Inc | 3.03% |
| Apogee Therapeutics Inc. | 2.96% |
| IONS Ionis Pharmaceuticals, Inc. | 2.72% |
| ARGX Argenx SE | 2.26% |
More on ETNHX.
- ETNHX overview
- ETNHX holdings
- ETNHX risk
- ETNHX costs
- ETNHX money in and out
- ETNHX share classes
- Compare ETNHX with other funds
Returns after fees, from the fund's SEC filings up to Mar 2026. Past returns are not a promise. Not financial advice.